Skip to main content

Table 1.

Patient characteristics

Characteristic n = 30
Male sex, n (%) 12 (40)
Age, median (range), y 33 (18-69)
Stage, n (%)
 I 1 (3)
 II 11 (37)
 III 7 (23)
 IV 11 (37)
B symptoms, n (%) 13 (43)
Mediastinal bulk, >10 cm, n (%) 6 (20)
Elevated erythrocyte sedimentation rate, >50, n (%) 11 (37)
Extranodal involvement, n (%) 11 (37)
Spleen involvement, n (%) 7 (23)
Early-stage unfavorable, National Comprehensive Cancer Network (n = 12), n (%) 6 (50)
International Prognostic Score (advanced stage, n = 18), n (%)
 0-1 6 (33)
 2 and 3 7 (39)
 4, 5, 6, and 7 5 (28)